ALIF-B AddLife AB (publ)

17.41USD176.60 SEK · STO-0.90%Mkt Cap: 2.12B USDP/E: 33.51

AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical ind…

Institutional holders10 on file

Key Statistics

Company
Market Cap2.12B USD
Enterprise Value2.60B USD
Revenue (TTM)1.05B USD
Gross Profit392.17M USD
Net Income (TTM)55.22M USD
Revenue/Share8.66 USD
Last Price17.41 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees2.4K
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINSE0014401378
Valuation
P/E (Trailing)33.51
P/E (Forward)55.53
PEG—
EV/EBITDA17.11
EV/Revenue2.47
P/S2.01
P/B3.61
EPS (TTM)0.52 USD
EPS (Forward)0.31 USD
52W Range
12.8474% of range19.01
52W High19.01 USD
52W Low12.84 USD
Profitability
Gross Margin38.09%
Oper. Margin8.93%
EBITDA Margin14.41%
Profit Margin5.36%
ROE10.29%
ROA4.41%
ROIC6.41%
ROCE9.51%
Growth
Revenue Growth7.00%
Earnings Growth57.90%
Cash Flow & Leverage
Operating CF137.26M USD
CapEx (TTM)28.01M USD
FCF Margin8.70%
FCF Yield4.33%
Net Debt459.72M USD
Net Debt/EBITDA3.02
Net Debt/FCF5.01
Balance Sheet
Debt/Equity0.88
Current Ratio0.65
Quick Ratio0.36
Book Value/Sh4.82 USD
Cash/Share0.39 USD
Dividends
Fwd Div Rate0.15 USD
Trail. Div Rate0.15 USD
Div. Yield0.84%
5Y Avg Yield0.56%
Payout Ratio28.46%
Ex-Div DateMay 7, 2026
Pay Date—
Splits
Last Split4:1
Split DateMay 27, 2020
Analyst Consensus
Rating—
Target (Mean)20.29 USD
Upside (mean)+16.5%
Target Range18.64 USD – 21.69 USD
18.64+16.5% to mean21.69
# Analysts4
Ownership
Shares Out.117.29M
Float113.30M
Insiders5.31%
Institutions78.43%
Technical
SMA 5017.24 (+1.0%)
SMA 20015.64 (+11.4%)
Beta1.53
S&P 52W Chg12.00%
Avg Vol (30d)197.28K
Avg Vol (10d)101.84K
Technical Indicators
RSI (14)43.9
MACD0.4290
MACD Signal1.6619
MACD Hist.-1.2329
BB Upper18.37 USD
BB Middle17.89 USD
BB Lower17.40 USD
BB Width5.39%
ATR (14)0.4010 USD
Vol Ratio (20d)0.64x

About AddLife (STO: ALIF-B)

›

AddLife (STO: ALIF-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 2,428 employees.

The shares were at 176.60 SEK on 20 November 2026, down 4.9% over 52 weeks. Its 52-week range is 130.20 SEK to 192.80 SEK: the price is 8.4% below the high and 35.6% above the low.

At a market capitalisation of 21.52B SEK, it trades at 33.5 times trailing earnings and 55.5 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 48.3, a discount of 31% for ALIF-B. It pays a dividend yielding 0.84% (it pays out 28% of its earnings), against a median of 0.92% among the dividend payers in that peer group.

AddLife reports return on equity of 10.3%, an operating margin of 8.9% and revenue up 7.0% year over year.

Its debt exceeds its cash by 4.66B SEK, a debt-to-equity ratio of 0.88. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 4 analysts cover the stock; their mean price target of 205.75 SEK is 16.5% above the current price. The next earnings report is expected on 3 February 2027.